HCW Biologics Inc. (HCWB) Total liabilities 2020–2025
HCW Biologics Inc. (HCWB) total liabilities at each fiscal year-end, per SEC filings.
$21.8MFY2025 · since FY2020: $32.1M → $21.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.8M | -41.2% |
| FY2024 | $37.0M | +145.9% |
| FY2023 | $15.1M | +60.5% |
| FY2022 | $9.4M | +304.1% |
| FY2021 | $2.3M | -92.8% |
| FY2020 | $32.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HCWB financial trends
HCWB RevenueHCWB Net incomeHCWB Net marginHCWB Gross profitHCWB Gross marginHCWB Operating incomeHCWB Operating marginHCWB Operating cash flowHCWB Free cash flowHCWB Capital expendituresHCWB Return on equityHCWB Stock buybacksHCWB Dividends paidHCWB Total assetsHCWB Shareholders’ equityHCWB overview →